Expert opinion on use of acalabrutinib for chronic lymphocytic leukemia treatment

Bartosz Puła, Elżbieta Iskierka-Jażdżewska, Krzysztof Jamroziak, Krzysztof Giannopoulos, Tomasz Wróbel, Tadeusz Robak, Iwona Hus

Vol 55, No 3 (2024)

Guidelines / Expert consensus

What’s new in chronic myelogenous leukemia and COVID-19?

Bartosz Puła

Vol 55, No 2 (2024)

Editorial

Myeloid/lymphoid neoplasm with eosinophilia and FIP1L1::PDGFRA presenting as chronic myeloproliferative neoplasm in the myeloid blast phase: a case report and a review of the literature

Dorota Stankevič, Agnieszka Końska, Kinga Kos-Zakrzewska, Iwona Solarska, Bożena Katarzyna Budziszewska, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Bartosz Puła

Vol 55, No 5 (2024)

Short communication

Acute intermittent porphyria: a diagnostic challenge.

Karol Bigosiński, Maciej Dubaj, Aneta Szudy-Szczyrek, Marek Hus

Vol 55, No 4 (2024)

Clinical vignette

Recommendations of Polish Adult Leukemia Group concerning diagnostics and treatment of polycythemia vera

Joanna Góra-Tybor, Tomasz Sacha, Maria Bieniaszewska, Marta Sobas, Krzysztof Lewandowski, Patryk Sobieralski, Olga Chyrko, Aleksandra Gołos

Vol 55, No 6 (2024)

Guidelines / Expert consensus

Professor Euzebiusz Krykowski (3 January 1927–21 March 2024)

Anna Korycka-Wołowiec Korycka-Wołowiec, Joanna Góra-Tybor, Jacek Treliński, Krzysztof Chojnowski, Tadeusz Robak, Agnieszka Wierzbowska

Vol 55, No 2 (2024)

Letter to the Editor

Changes in the nutritional status of children with cancer depending on clinical, demographic and social factors

Anna Milaniuk, Katarzyna Drabko

Vol 55, No 5 (2024)

Original research article

Checkpoint inhibitors as potential therapeutics in acute myeloid leukemia

Krzysztof Bieliński, Bartosz Puła, Łukasz Bołkun

Vol 55, No 6 (2024)

Review article

Ischemic stroke as a consequence of acute hemolytic anemia following arsenic poisoning.

Malgorzata Elżbieta Poniatowska, Izabela Molka, Tomasz Janus, Barbara Potocka-Banaś, Krzysztof Kowalik, Marta Niewiadomska, Justyna Jabłońska-Odroniec, Katarzyna Brzeźnikiewicz-Janus

Vol 55, No 4 (2024)

Clinical vignette

Treatment options for anaemia in myelofibrosis

Aleksandra Gołos, Joanna Góra-Tybor

Vol 55, No 6 (2024)

Review article

KMT2a-rearranged acute leukaemias — insights and potential therapeutic options

Ogochukwu Izuegbuna

Vol 56, No 1 (2025)

Review article

Use of vedolizumab in children with steroid-refractory gastro-intestinal graft-versus-host disease

Joanna Cisek, Anna Dąbrowska, Agnieszka Majk, Krzysztof Czyżewski

Vol 55, No 5 (2024)

Short communication

Mutation status of immunoglobulin variable heavy chain genes (IGHV) — from immunological curiosity to forefront of diagnostics in chronic lymphocytic leukaemia

Tomasz Stokłosa

Vol 55, No 6 (2024)

Editorial

Evaluation of serological and hematological parameters in donors of SARS-CoV-2 convalescent plasma of respect to time periods of donation

Marta Stanek, Anna Leśków, Małgorzata Szymczyk-Nużka, Anita Wojciechowska-Chorębała, Dorota Diakowska

Vol 55, No 3 (2024)

Original research article

Endothelial dysfunction and thrombosis in polycythemia vera

Weronika Marzena Lebowa, Patrycja Lebowa, Tomasz Sacha

Vol 55, No 6 (2024)

Review article